Home
Schonfeld Strategic Advisors reported a 3.6% stake in Skye Bioscience SKYE · 1,115,939 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 3.6%
- Last report
- 5.22% · filed 25/05/15
- Shares held
- 1,115,939 sh
- Class
- Common Stock, par value $0.001 per share
- Stock
- Skye Bioscience SKYE
- Event date
- 25/06/30
- Filed
- 25/08/14
3.6% stake · below 5%
- Stake
- 3.6%
- Last report
- 5.22%
- Since last report
- −1.6pp
Skye Bioscience trades, last 26 weeks
What else happened in Skye Bioscience around then
Filed or reported within 30 days of the trade day · 25/05/31~25/07/30Schonfeld Strategic Advisors's other 5% stake reports
- Schonfeld Strategic Advisors
5% stakeInhibrx Biosciences
5% stakeInhibrx Biosciences
INBX
5.33% stake
781,678 sh
5.33% stake
Filed 08/14
- Schonfeld Strategic Advisors
5% stakeCardinal Infrastructure Group
5% stakeCardinal Infrastructure Group
CDNL
2.88% stake
439,707 sh
2.88% stake
Filed 05/15
- Schonfeld Strategic Advisors
5% stakeJiuzi Holdings
5% stakeJiuzi Holdings
JZXN
0% stake
0 sh
0% stake
Filed 02/17
- Schonfeld Strategic Advisors
5% stakeCardinal Infrastructure Group
5% stakeCardinal Infrastructure Group
CDNL
8.6% stake
1,285,430 sh
8.6% stake
Filed 02/17
- Schonfeld Strategic Advisors
5% stakeFate Therapeutics
5% stakeFate Therapeutics
FATE
0.82% stake
937,521 sh
0.82% stake
Filed 25/08/14
